A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

PHASE4CompletedINTERVENTIONAL
Enrollment

947

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

November 30, 2015

Conditions
Migraine
Interventions
DRUG

Tianshu capsule

DRUG

Sugar pill

Trial Locations (20)

100039

Chinese PLA General Hospital, Beijing

102600

Daxing hospital of Traditional Chinese Medicine, Beijing

130117

The Affiliated Hospital of Changchun University of Chinese medicine, Changchun

136000

Jilin brain hospital, Siping

235000

The People's Hospital,Huaibei, Huaibei

250000

Jinan hospital of traditional Chinese Medicine, Jinan

The second affiliated hospital of Shandong Traditional Chinese Medicine University, Jinan

272000

Affiliated Hospital of Jining Medical University, Jining

Jining First Hospital, Jining

362002

Quanzhou First Hospita, Quanzhou

365000

SanMing First Hospital, Sanming

413000

Yiyang central hospital, Yiyang

430000

Wuhan sixth hospital, Wuhan

462000

Luohe hospital of Traditional Chinese Medicine, Luohe

475000

Kaifeng hospital of Traditional Chinese Medicine, Kaifeng

710021

Xi An Hospital of Traditional Chinese Medicine, Xian

061000

The People's Hospital,Cangzhou, Cangzhou

065000

Langfang hospital of Traditional Chinese Medicine, Langfang

050000

The two six zero hospital of Chinese people's Liberation Army, Shijiazhuang

063000

Tangshan TCM Hospital, Tangshan

All Listed Sponsors
collaborator

Beijing Bionovo Medicine Development Co., Ltd.

OTHER

lead

Jiangsu Kanion Pharmaceutical Co., Ltd

INDUSTRY

NCT02035111 - A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine. | Biotech Hunter | Biotech Hunter